Article
MALDI-TOF MS-based SNP assay used to determine the appropriate antidepression for Chinese patients.
Journal of pharmaceutical and biomedical analysis - 1 Jan 2025
Zhang Zi, Guo Zhihao, Gan Tongying, Huang Shanqing, Shang Dewei
Abstract excerpt
Medicine remains the preferred primary treatment for depression, although some patients show remarkable individual variations in achieving satisfactory clinical outcomes during medication. Genetic polymorphisms cause approximately 40 % of individual differences in treatment response. Therefore, this study aimed to develop a technique to identify single nucleotide polymorphisms (SNPs) associated with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
